BioNTech's decision to acquire Instadeep was driven by several factors, including the company's desire to accelerate its development of new vaccines and treatments. By acquiring Instadeep, BioNTech gained access to the company's proprietary AI algorithm and expertise, which can be used to improve the development and analysis of new therapies.
The acquisition also marked a significant milestone for Instadeep, which became one of the largest tech acquisitions from Africa to date. The deal provided Instadeep with the necessary resources to scale its operations and expand its product offerings, while also giving BioNTech access to Instadeep's innovative AI technologies.